×

Message

EU e-Privacy Directive

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

View e-Privacy Directive Documents

You have declined cookies. This decision can be reversed.

SCENAR Therapy (electronic biofeedback)

The use of electronic biofeedback for the management of post-herpetic neuralgia--a report of 3 cases.

Written by CYBERMED LIFE NEWS
Abstract Title:

The use of electronic biofeedback for the management of post-herpetic neuralgia--a report of 3 cases.

Abstract Source:

Hawaii Med J. 2007 Sep;66(9):232, 234. PMID: 20879466

Abstract Author(s):

Malcolm R Ing

Article Affiliation:

Division of Ophthalmology, John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawai'i, USA. This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract:

The purpose of these case reports is to describe treatment of three consecutive patients with post-herpetic neuralgia using a bioelectronical device (SCENAR). The instrument is approved as a Class II device in the United States. The electrode of the device was stroked gently over the involved skin area for up to 15 minutes per session. No more than 5 sessions over a 3-week period was required. All patients experienced substantial relief of pain from the first treatment. One patient required only 1 treatment lasting 10 minutes. The other 2 patients required 4 to 5 treatments over a 3-week period. One patient required a treatment for skin itch after one year with a follow up period of 6 months to 24 months. An electronic biofeedback device (SCENAR) may be successfully utilized in the management of post-herpetic neuralgia.